Table 3 Causes of Trastuzumab Discontinuation
Adverse events | Total (n = 106) |
|---|---|
n (%) | |
Cardiomyopahy | 66 (62%) |
Neutropenia | 16 (15%) |
Disease Progression | 5 (5%) |
Patient Preference | 4 (4%) |
Thrombocytopenia | 3 (3%) |
Shortness of Breath | 2 (2%) |
Others | 10 (9%) |
Adverse events | Total (n = 106) |
|---|---|
n (%) | |
Cardiomyopahy | 66 (62%) |
Neutropenia | 16 (15%) |
Disease Progression | 5 (5%) |
Patient Preference | 4 (4%) |
Thrombocytopenia | 3 (3%) |
Shortness of Breath | 2 (2%) |
Others | 10 (9%) |